Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure

被引:274
作者
Oelkers, WKH
机构
关键词
estrogen; progestogen; angiotensinogen; renin; aldosterone; blood pressure;
D O I
10.1016/0039-128X(96)00007-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endogenous (17)beta-estradiol (E2) and low parenteral doses of exogenous E2 are vasodilators. High dose estrogens, especially ethinylestradiol (EE) and mestranol, stimulate the synthesis of hepatic proteins including coagulation factors, sex hormone binding globulin, and angiotensinogen (Aogen). In the steady state, high plasma levels of Aogen produce only a very small increase of angiotensin II (AII) and plasma renin activity, because AII inhibits the secretion of renin and lowers plasma renin concentration. However, the increase in AII is sufficient for a slight reduction in renal blood flow and a slight increase in exchangeable sodium and blood pressure; in susceptible women, blood pressure may rise considerably. Effects of estrogens on the brain may also be involved in blood pressure changes. Endogenous progesterone is a mineralocorticoid receptor antagonist. Endogenous or exogenous progesterone lends to sodium loss and a compensatory increase in renin secretion, plasma renin activity, AII, and plasma aldosterone, e.g. in the second half of the menstrual cycle. Synthetic progestogens are commonly devoid of the mineralocorticoid receptor antagonistic effect of progesterone, and some are weak estrogen receptor agonists. Combined use of EE and synthetic progestogens may therefore enhance estrogen effects on body sodium and blood pressure. A new progestogen (Drospirenone) with an antimineralocorticoid effect like that of progesterone is described that slightly lowers body weight and blood pressure in a contraceptive formulation together with EE. An almost ideal oral contraceptive would be a progestogen like Drospirenone together with a low dose natural estrogen that does not stimulate Aogen synthesis. Since most oral formulations for postmenopausal estrogen replacement also stimulate hepatic protein synthesis (including Aogen) to some extent, the transdermal route of E2 application for contraceptive purposes should also be investigated, since it has a reduced potential for undesirable side effects.
引用
收藏
页码:166 / 171
页数:6
相关论文
共 50 条
[1]  
BECKERHOFF R, 1973, JOHNS HOPKINS MED J, V132, P80
[2]  
BONNAR J, 1991, ADV CONTRACEPT S3, V7, P285
[3]   ESTROGEN AUGMENTS THE CONTRIBUTION OF NITRIC-OXIDE TO BLOOD-PRESSURE REGULATION IN TRANSGENIC HYPERTENSIVE RATS EXPRESSING THE MOUSE REN-2 GENE [J].
BROSNIHAN, KB ;
MORIGUCHI, A ;
NAKAMOTO, H ;
DEAN, RH ;
GANTEN, D ;
FERRARIO, CM .
AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (07) :576-582
[4]   EFFECTS OF 17-BETA-ESTRADIOL AND PROGESTERONE ON PRESSER RESPONSES IN CONSCIOUS OVARIECTOMIZED RATS [J].
CONRAD, KP ;
MOSHER, MD ;
BRINCKJOHNSEN, T ;
COLPOYS, MC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (04) :R1267-R1272
[5]   HYPERTENSION, ORAL CONTRACEPTIVE AGENTS, AND CONJUGATED ESTROGENS [J].
CRANE, MG ;
HARRIS, JJ ;
WINSOR, W .
ANNALS OF INTERNAL MEDICINE, 1971, 74 (01) :13-+
[6]  
Crane MG., 1974, ORAL CONTRACEPTIVES, P159
[7]   BIOLOGICAL EFFECTS OF ESTRADIOL-17-BETA-IN POSTMENOPAUSAL WOMEN - ORAL VERSUS PERCUTANEOUS ADMINISTRATION [J].
DELIGNIERES, B ;
BASDEVANT, A ;
THOMAS, G ;
THALABARD, JC ;
MERCIERBODARD, C ;
CONARD, J ;
GUYENE, TT ;
MAIRON, N ;
CORVOL, P ;
GUYGRAND, B ;
MAUVAISJARVIS, P ;
SITRUKWARE, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (03) :536-541
[8]   COMPARATIVE METABOLIC STUDY OF PERCUTANEOUS VERSUS ORAL MICRONIZED 17-BETA-ESTRADIOL IN REPLACEMENT THERAPY [J].
DEMOUSTIER, BF ;
CONARD, J ;
GUYENE, TT ;
SITT, Y ;
DENYS, I ;
ARNOUXROUVEYRE, M ;
PELISSIER, C .
MATURITAS, 1989, 11 (04) :275-286
[9]   IMMUNOREACTIVE RENIN, PRORENIN, AND ENZYMATICALLY ACTIVE RENIN IN PLASMA DURING PREGNANCY AND IN WOMEN TAKING ORAL-CONTRACEPTIVES [J].
DERKX, FHM ;
STUENKEL, C ;
SCHALEKAMP, MPA ;
VISSER, W ;
HUISVELD, IH ;
SCHALEKAMP, MADH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04) :1008-1015
[10]  
FOWLER WL, 1986, AM J PHYSIOL, V250, pH190